B C Ferreira1,2,3, P Sá-Couto4, M C Lopes5, L Khouri6. 1. I3N Physics Department, Aveiro University, Aveiro, Portugal. bcf@estsp.ipp.pt. 2. School of Allied Health Technologies, Polytechnic Institute of Porto, Porto, Portugal. bcf@estsp.ipp.pt. 3. , Rua Valente Perfeito, 322, gab 20, 4400-330, Vila Nova de Gaia, Portugal. bcf@estsp.ipp.pt. 4. Department of Mathematics, Center for Research and Development in Mathematics and Applications, Aveiro University, Aveiro, Portugal. 5. Medical Physics Department, Portuguese Institute of Oncology of Coimbra Francisco Gentil, Coimbra, Portugal. 6. Radiation Therapy Department, Portuguese Institute of Oncology of Coimbra Francisco Gentil, Coimbra, Portugal.
Abstract
AIMS: The aims of the study were to evaluate head and neck cancer (HNC) patient's compliance to the planned radiation therapy (RT) using the department policy established in 2005 at IPOCFG and to estimate the impact on treatment outcome due to failure in receiving RT as prescribed. MATERIALS AND METHODS: 359 HNC patients irradiated from 2007 to 2013 were included in this study. Patient cohort was divided into Group 1: patients receiving RT as prescribed and Group 2: patients that interrupted or suspended RT. Group Tox is the subgroup of patients that interrupted RT due to toxicity or intercurrent disease. Number and causes for treatment interruptions were assessed. The cumulative incidence of locoregional control (LRC), disease-free survival (DFS) and overall survival for Groups 1 and 2 was determined. Cox regression was performed to investigate potential hazard factors and logistic regression was made to determine risk factors related to treatment interruptions. RESULTS: Major causes for treatment interruptions were toxicity plus intercurrent disease (41.7 %) and public holidays (30.1 %). 10.3 % of the patients interrupted 3-9 days. Significant differences in survival distributions of the LRC between Groups 1 and 2, of up to 19 %, were found in the subgroup of patients with N2-3 tumours, for post-operative RT and for concomitant RT. Treatment breaks larger than two days had an almost fourfold increased risk of poorer LRC and DFS. CONCLUSIONS: Twin accelerators and treating on public holidays are effective measures minimizing RT breaks. For HNC, patient compliance is mostly limited by RT side-effects. Efforts to maintain RT biological effective dose in HNC must be always undertaken.
AIMS: The aims of the study were to evaluate head and neck cancer (HNC) patient's compliance to the planned radiation therapy (RT) using the department policy established in 2005 at IPOCFG and to estimate the impact on treatment outcome due to failure in receiving RT as prescribed. MATERIALS AND METHODS: 359 HNC patients irradiated from 2007 to 2013 were included in this study. Patient cohort was divided into Group 1: patients receiving RT as prescribed and Group 2: patients that interrupted or suspended RT. Group Tox is the subgroup of patients that interrupted RT due to toxicity or intercurrent disease. Number and causes for treatment interruptions were assessed. The cumulative incidence of locoregional control (LRC), disease-free survival (DFS) and overall survival for Groups 1 and 2 was determined. Cox regression was performed to investigate potential hazard factors and logistic regression was made to determine risk factors related to treatment interruptions. RESULTS: Major causes for treatment interruptions were toxicity plus intercurrent disease (41.7 %) and public holidays (30.1 %). 10.3 % of the patients interrupted 3-9 days. Significant differences in survival distributions of the LRC between Groups 1 and 2, of up to 19 %, were found in the subgroup of patients with N2-3 tumours, for post-operative RT and for concomitant RT. Treatment breaks larger than two days had an almost fourfold increased risk of poorer LRC and DFS. CONCLUSIONS: Twin accelerators and treating on public holidays are effective measures minimizing RT breaks. For HNC, patient compliance is mostly limited by RT side-effects. Efforts to maintain RT biological effective dose in HNC must be always undertaken.
Entities:
Keywords:
Clinical outcome; Head and neck cancer; IMRT; Radiation therapy; Treatment interruptions
Authors: Vincent Grégoire; Peter Levendag; Kian K Ang; Jacques Bernier; Marijel Braaksma; Volker Budach; Cliff Chao; Emmanuel Coche; Jay S Cooper; Guy Cosnard; Avraham Eisbruch; Samy El-Sayed; Bahman Emami; Cai Grau; Marc Hamoir; Nancy Lee; Philippe Maingon; Karin Muller; Hervé Reychler Journal: Radiother Oncol Date: 2003-12 Impact factor: 6.280
Authors: Patti A Groome; Brian O'Sullivan; William J Mackillop; Lynda D Jackson; Karleen Schulze; Jonathan C Irish; Padraig R Warde; Ken M Schneider; Robert G Mackenzie; D Ian Hodson; J Alex Hammond; Sunil P P Gulavita; Libni J Eapen; Peter F Dixon; Randy J Bissett Journal: Int J Radiat Oncol Biol Phys Date: 2006-01-18 Impact factor: 7.038
Authors: Narek Shaverdian; Vinai Gondi; Kathryn L Sklenar; Emily F Dunn; Daniel G Petereit; Margaret R Straub; Kristin A Bradley Journal: Int J Radiat Oncol Biol Phys Date: 2013-04-02 Impact factor: 7.038
Authors: Donald M Cannon; Heather M Geye; Gregory K Hartig; Anne M Traynor; Tien Hoang; Timothy M McCulloch; Peggy A Wiederholt; Richard J Chappell; Paul M Harari Journal: Head Neck Date: 2013-11-27 Impact factor: 3.147
Authors: Megan Dann Fesinmeyer; Vivek Mehta; David Blough; Lauri Tock; Scott D Ramsey Journal: Int J Radiat Oncol Biol Phys Date: 2010-02-03 Impact factor: 7.038
Authors: A Fondevilla Soler; J L López-Guerra; A García Fernández; M A Samaniego Conde; M J Belmonte González; J M Praena-Fernandez; E Rivin Del Campo; M Alcaraz; I Azinovic Journal: Clin Transl Oncol Date: 2018-11-30 Impact factor: 3.405
Authors: Michael S Chin; Leah Siegel-Reamer; Gordon A FitzGerald; Allison Wyman; Nikole M Connor; Yuan-Chyuan Lo; Shirin Sioshansi; Janaki Moni; Maria Giulia Cicchetti; Janice F Lalikos; Thomas J FitzGerald Journal: Clin Transl Radiat Oncol Date: 2017-05-18